Pharma News

Following the successful election of Donald Trump as the 47th President of the United States, India's life sciences and pharmaceutical industries are watching closely to see how the new administration's "America First" policies will affect US trade dynami

AstraZeneca announced on Wednesday that its China chief, Leon Wang, had been detained by Chinese authorities. Although the specific reason for the detention is unclear, the company said it does not believe the incident is related to a major health insuran

Danish biotech company Zealand Pharma announced in a statement on Thursday that they expect to initiate a phase 2b clinical trial of petrelintide, its candidate for the treatment of obesity, in the fourth quarter of 2024.

On November 6, 2024, Novo Nordisk announced its financial results for the third quarter of 2024.

According to the results of the National Enterprise Credit Information Disclosure System, Astrazeneca's legal representative, responsible person, chief representative and executive of partnership affairs have been changed.

At Viking's ObesityWeek conference on Sunday, data from a study got a lot of attention. The early study, which included 92 participants, showed that those who took a 100 mg dose of Viking tablets lost an average of 6.8 percent of their body weight in just

On October 28, 2024, AbbVie, the world's leading pharmaceutical company, announced a major transaction to acquire all outstanding shares of Aliada for $1.4 billion in cash.

In order to maintain its leading position in the weight loss drug market, Novo Nordisk is currently actively developing a new GLP-1 drug called CagriSema, according to the latest media reports.

The investment in Fortvita, the market is highly concerned about the actions of innovative pharmaceutical companies, which is a supervisory force, which is also increasingly normal for innovative pharmaceutical companies.

Late on October 30, Astrazeneca's official website announced that Wang Lei, global executive vice president, chairman of international operations and president of China, is facing investigation.

Novo Nordisk recently announced primary results from Part 1 of its ongoing pivotal Phase 3 clinical trial of ESSENCE. A detailed analysis of the study showed that Wegovy (semaglutide), a weight-loss therapy developed by the company, significantly reduced

Recently, Zhaoke Ophthalmology Company announced an exciting news that the company's eye drug candidate NVK002 has achieved impressive positive results in the Phase III clinical trial (China CHAMP).

On Tuesday, October 29, Eastern time, Bloomberg published an interesting story. According to an inspection report released by the U.S. Food and Drug Administration (FDA) in March this year, the FDA conducted a detailed investigation of the Novo Nordisk pl

Eli Lilly (LLY), Merck (MRK), Pfizer (PFE), AbbVie ABBV (ABBV), and Novartis (Novartis) are among the big names reporting third-quarter financial results this week.

Donald Trump's endorsement of Robert F. Kennedy Jr. and his fringe health theory has drawn much attention in Washington and beyond, with powerful agricultural interests scrambling to protect their industry from the potential impact of Kennedy's theory.

More than a year ago, New Zealand customs officials began intercepting several batches of injections marked with the brands Fitaro and Orsema, produced by the little-known Bangladeshi pharmaceutical company Incepta Pharmaceuticals.

The independent advisory committee of the U.S. Food and Drug Administration (FDA) voted on Thursday to deny a recommendation for Lexicon Pharmaceuticals' drug for additional treatment beyond insulin therapy to control blood glucose levels in adults with T

U.S. pharmaceutical and biotechnology companies have increasingly relied on Chinese partners for production, research, and raw material supply. However, as geopolitical tensions escalate, some companies are seeking alternative options.

Legal advisers for AstraZeneca, Bristol Myers Squibb and Johnson & Johnson filed a petition on Wednesday with the federal appeals court in Philadelphia to rehear a lawsuit The lawsuit challenges the first law in US history to force drug companies to negot

Takeda Pharmaceutical, Japan's largest drugmaker, reported second-quarter earnings on Thursday that beat market expectations. The company also raised its full-year earnings forecast.